From the New York Times:
F.D.A. Faults Quality of Imported Drugs
Most imported drugs are counterfeit knockoffs that could seriously endanger the health of those taking them, say federal drug and customs officials who conducted a spot inspection over the summer that they disclosed yesterday.

The inspection "illustrates the real and serious public health risks created by the importation of unapproved drugs," said Mark B. McClellan, commissioner of the Food and Drug Administration.

William K. Hubbard, an associate F.D.A. commissioner, added that proposals in Congress to legalize drug imports "would open up the floodgates to many of these drugs and would encourage folks with the government's imprimatur to buy drugs that nobody has any regulatory authority over."


From the Washington Post:
FDA Steps Up Enforcement on Drug Imports
As a growing number of governors say they intend to defy federal regulators and purchase lower-cost prescription drugs from Canada, the Bush administration is pushing back, stepping up its enforcement actions against what it describes as "illegal and potentially dangerous" shipments from abroad.

From the Washington Post:
The Great Pharmacy To the North
Roland and Carolyn Watson of Towson, Md., didn't know they were getting into a war when they bought prescription drugs from a pharmacist in Canada, but that's the only way they can afford the drug Carolyn needs for her Parkinson's disease. Instead of a drug benefit under Medicare, the Watsons have the Buy Canada Drug Plan.